New psychiatric drugs low priority for pharmaceutical firms

Sunday, October 14, 2012 - 10:00 in Health & Medicine

The pharmaceutical industry has largely abandoned drug development for mental illnesses even though depression is a leading cause of disability, experts say.

Read the whole article on CBC: Health

More from CBC: Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net